Clinical Trials · NCT05854784
Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 6
- Start date
- Mar 2023
- Locations
- 1 site, Netherlands
- Primary endpoint
- The Change in Disease Severity in Patients With VP as Measured by CGIC.